Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Survivin and Telomerase as Radiotherapeutic Response Predictors of Subjects with Stage IIIB Cervical Squamous Cell Carcinoma

The Indonesian Biomedical Journal · Vol. 12 No. 1 (2020) · hlm. 27–33

DOI
10.18585/inabj.v12i1.813
ISSN
2085-3297, 2355-9179
Terbit
2020-03-19
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Cervical cancer is one of the most prevalent cancers in women. Even with similar clinicopathologic features, radiotherapy outcomes are still vary among patients. This research was conducted to measure radiotherapy responses on cervical cancer patients by using Survivin, Telomerase and Cytochrome C.METHODS: Subjects who matched the criteria were selected and requested to fill questionnaires. Subjects were then evaluated with magnetic resonance imaging (MRI) pre- and post-3D conformal radiotherapy. Histopathological study was conducted using resected tumors to determine the differentiation type. Enzyme-linked Immunosorbent Assays for detection of Survivin, Telomerase and Cytochrome C was performed using the resected tumors as well.RESULTS: There were 76 patients in this study. Mean ofage was 50 and diameter of tumor size was 5.35 cm. Mean levels of Survivin, Telomerase and Cytochrome C were 632.82 pg/mL, 5.59 pg/mL and 204.75 ng/mL, respectively. There were significant correlations between radiotherapy response and Survivin (p=0.041) or Telomerase (p=0.022). Subjects with lower Survivin level (<932 pg/mL) had higher 1-year survival rate (63%) than subjects with higher Survivin level (50%). Similar results were obtained for subjects with lower Telomerase level (<5.75 pg/mL), who had higher 1-year survival rate (60%) than subjects with higher Telomerase level (43%).CONCLUSION: Since radiotherapy response is significantly correlated with Survivin and Telomerase levels and subjects with lower Survivin or Telomerase level have higher 1-year survival rate, it can be suggested that Survivin and Telomerase could be potential predictors of radiotherapeutic response for subjects with stage IIIB cervical squamous cell carcinoma.KEYWORDS: cervical cancer, radiotherapy Survivin, Telomerase, Cytochrome C

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 102 tautan kepenulisan bersama · 55 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Indonesia
  • Universitas Trisakti
  • University of Brawijaya
  • PT Prodia StemCell Indonesia (Indonesia)
  • Kyushu University
  • Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
  • Padjadjaran University
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Muhammad Ihsan RizalUniversitas Trisakti5
Nurrani Mustika DewiPadjadjaran University5
Dewi RanggainiUniversitas Trisakti5
Melanie Sadono DjamilUniversitas Trisakti5
Heri WibowoUniversity of Indonesia5
Janti SudionoUniversitas Trisakti4
Johni HalimUniversitas Trisakti4
Angliana ChouwPT Prodia StemCell Indonesia (Indonesia)4
Djanggan SargowoUniversity of Brawijaya4
Visi Endah PratitisAfiliasi tidak diketahui4
Irawan YusufHasanuddin University4
Tjam Diana SamaraUniversitas Trisakti4
Isabella Kurnia LiemUniversity of Indonesia4
Wahyu WidowatiMaranatha Christian University3
Yanni DirgantaraPT Prodia StemCell Indonesia (Indonesia)3
Maria CelinnaAfiliasi tidak diketahui3
Toshio KukitaKyushu University3
Alifah Evi ScaniaUniversity of Indonesia3
Kyung Hoon LeeAfiliasi tidak diketahui3
Roya Khosravi‐FarBeth Israel Deaconess Medical Center3
Lely WahyuniarJoint United Nations Programme on HIV/AIDS2
Abas B. DjauhariKementerian Kesehatan Republik Indonesia2
Ratna DjuwitaUniversity of Indonesia2
Ketherin KetherinUniversitas Trisakti2
Tjandrawati MozefIndonesian Institute of Sciences2
Ardian RizalUniversity of Brawijaya2
Tadahiko IijimaKyushu University2
Sonar Soni PanigoroRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo2
Herqutanto HerqutantoUniversity of Indonesia2
Solachuddin Jauhari Arief IchwanUniversiti Brunei Darussalam2
Andon HestiantoroRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo2
Nyoman Suci WidyastitiDiponegoro University2
Pudji RahajuUniversity of Brawijaya2

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Survivin and Telomerase as Radiotherapeutic Response Predictors of Subjects with Stage IIIB Cervical Squamous Cell Carcinoma</dc:title><dc:creator>Fitriyadi Kusuma</dc:creator><dc:creator>Andrijono Andrijono</dc:creator><dc:creator>Ani Retno Prijanti</dc:creator><dc:creator>Laila Nuranna</dc:creator><dc:creator>Sri Mutya Sekarutami</dc:creator><dc:creator>Bambang Sutrisna</dc:creator><dc:creator>Ferry Sandra</dc:creator><dc:subject>cervical squamous cell carcinoma</dc:subject><dc:subject>stage IIIB cervical cancer</dc:subject><dc:subject>radiotherapy response prediction</dc:subject><dc:subject>survivin</dc:subject><dc:subject>telomerase</dc:subject><dc:subject>cytochrome c</dc:subject><dc:subject>3D conformal radiotherapy</dc:subject><dc:subject>tumor markers</dc:subject><dc:subject>one-year survival</dc:subject><dc:description xml:lang="en">BACKGROUND: Cervical cancer is one of the most prevalent cancers in women. Even with similar clinicopathologic features, radiotherapy outcomes are still vary among patients. This research was conducted to measure radiotherapy responses on cervical cancer patients by using Survivin, Telomerase and Cytochrome C.METHODS: Subjects who matched the criteria were selected and requested to fill questionnaires. Subjects were then evaluated with magnetic resonance imaging (MRI) pre- and post-3D conformal radiotherapy. Histopathological study was conducted using resected tumors to determine the differentiation type. Enzyme-linked Immunosorbent Assays for detection of Survivin, Telomerase and Cytochrome C was performed using the resected tumors as well.RESULTS: There were 76 patients in this study. Mean ofage was 50 and diameter of tumor size was 5.35 cm. Mean levels of Survivin, Telomerase and Cytochrome C were 632.82 pg/mL, 5.59 pg/mL and 204.75 ng/mL, respectively. There were significant correlations between radiotherapy response and Survivin (p=0.041) or Telomerase (p=0.022). Subjects with lower Survivin level (&lt;932 pg/mL) had higher 1-year survival rate (63%) than subjects with higher Survivin level (50%). Similar results were obtained for subjects with lower Telomerase level (&lt;5.75 pg/mL), who had higher 1-year survival rate (60%) than subjects with higher Telomerase level (43%).CONCLUSION: Since radiotherapy response is significantly correlated with Survivin and Telomerase levels and subjects with lower Survivin or Telomerase level have higher 1-year survival rate, it can be suggested that Survivin and Telomerase could be potential predictors of radiotherapeutic response for subjects with stage IIIB cervical squamous cell carcinoma.KEYWORDS: cervical cancer, radiotherapy Survivin, Telomerase, Cytochrome C</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2020-03-19</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v12i1.813</dc:identifier><dc:identifier>10.18585/inabj.v12i1.813</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 12 No 1 (2020); 27-33</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/813/459</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>